Physician profile
Benjamin Stockton
NPI 1770515959
$6,177.76
in general payments reported to CMS, 2019-2025
43 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $196 · 2021: $304 · 2022: $505 · 2023: $1,496 · 2024: $1,423 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,653 · Travel and Lodging: $17.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,652.80 |
| Travel and Lodging | $17.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $633.47 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $481.52 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $436.65 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $371.52 | 2023-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $301.76 | 2019-2025 | |
| Abbvie INC. | $295.47 | 2022-2025 | Avycaz, Botox |
| Calyxo, INC. | $292.27 | 2024-2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $255.72 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $231.69 | 2024-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $227.18 | 2023-2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $220.45 | 2023-2025 | Provenge |
| Merck Sharp & Dohme LLC | $203.89 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Boston Scientific Corporation | $168.37 | 2019-2024 | Ams 700, Rezum Generator |
| Intuitive Surgical, INC. | $160.92 | 2019-2023 | Da Vinci Surgical System |
| Ferring Pharmaceuticals INC. | $159.60 | 2024-2025 | Adstiladrin |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $150.38 | 2020-2025 | Speedicath, Luja Coude |
| Halozyme INC | $149.65 | 2023 | |
| Urogen Pharma, INC. | $149.34 | 2021-2025 | Jelmyto |
| Angiodynamics, INC. | $140.91 | 2025 | Nanoknife |
| 180 Medical, INC. | $127.05 | 2022-2024 | Gentlecath Glide |
| Alnylam Pharmaceuticals INC. | $109.79 | 2022-2025 | Givlaari, Oxlumo |
| Novartis Pharmaceuticals Corporation | $99.90 | 2024-2025 | |
| Blue Earth Diagnostics | $83.39 | 2024-2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $76.35 | 2020-2024 | Lynparza |
| Olympus America INC. | $68.43 | 2019-2024 | Itind System |
| Endo Pharmaceuticals INC. | $66.67 | 2019-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $56.57 | 2024-2025 | Xiaflex, Aveed |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Medtronic, INC. | $44.72 | 2023-2024 | Interstim |
| Laborie Medical Technologies Corp. | $43.39 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $34.64 | 2023-2024 | |
| Axonics, INC. | $32.08 | 2022-2023 | Axonics |
| Sun Pharmaceutical Industries INC. | $31.79 | 2024 | |
| Myovant Sciences INC. | $31.56 | 2021-2022 | |
| Cook Medical LLC | $30.13 | 2020-2021 | |
| Davol INC. | $28.29 | 2024 | Channel Drain |
| Teleflex LLC | $26.95 | 2021 | |
| Allergan, INC. | $26.58 | 2019 | |
| Inspire Medical Systems, INC. | $18.52 | 2025 | Inspire |
| Procept Biorobotics Corporation | $17.89 | 2024 | Aquabeam System |
| Bioprotect Medical, INC. | $15.30 | 2025 | Bioprotect Balloon Implant System |
| Baxter Healthcare | $14.87 | 2023 | Tisseel |
| Accord Healthcare, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Stockton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.